Collaborative approach improves outcomes for rare cancer research

The ISGACA initiative successfully united over 60 medical centers globally, gathering data from 4,309 patients to enhance treatment strategies for non-pancreatic periampullary cancers. By establishing a structured methodology, the group facilitated nine publications, secured research grants, and initiated a prospective multicenter clinical trial. The collaborative efforts of ISGACA resulted in uniform definitions and classifications, showcasing a promising framework for standardizing care and addressing the needs of patients with rare cancers.